New drugs in gastrointestinal stromal tumors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference32 articles.
1. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor;Heinrich;J Clin Oncol,2003
2. Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase;Mol;J Biol Chem,2004
3. Ripretinib (DCC-2618) is a switch control kinase inhibitor of a broad spectrum of oncogenic and drug-resistant KIT and PDGFRA variants;Smith;Cancer cell,2019
4. Discovery of conformational control inhibitors switching off the activated c-KIT and targeting a broad range of clinically relevant c-KIT mutants;Wu;J Med Chem,2019
5. Mechanisms of receptor tyrosine kinase activation in cancer;Du;Mol Cancer,2018
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review;Experimental Hematology & Oncology;2024-04-13
2. Immunotherapy of gastrointestinal stromal tumors: current view and future directions;Advances in Molecular Oncology;2023-07-10
3. Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-06
4. Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors;Cancers;2022-12-29
5. Drugs In The GIST Field (Therapeutic Targets And Clinical Trial Staging);Current Drug Delivery;2022-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3